Cargando…
Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors
Pancreatic neuroendocrine tumors (pNETs) are relatively rare heterogenous tumors, comprising only 1–2% of all pancreatic neoplasms. The majority of pNETs are non-functional tumors (NF-pNETs) that do not produce hormones, and as such, do not cause any hormone-related symptoms. As a result, these tumo...
Autores principales: | Hontani, Koji, Tsuchikawa, Takahiro, Hiwasa, Takaki, Nakamura, Toru, Ueno, Takashi, Kushibiki, Toshihiro, Takahashi, Mizuna, Inoko, Kazuho, Takano, Hironobu, Takeuchi, Satoshi, Dosaka-Akita, Hirotoshi, Kuwatani, Masaki, Sakamoto, Naoya, Hatanaka, Yutaka, Mitsuhashi, Tomoko, Shimada, Hideaki, Shichinohe, Toshiaki, Hirano, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739727/ https://www.ncbi.nlm.nih.gov/pubmed/29290942 http://dx.doi.org/10.18632/oncotarget.22175 |
Ejemplares similares
-
Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice
por: Takano, Hironobu, et al.
Publicado: (2015) -
Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation
por: Sato, Shoki, et al.
Publicado: (2017) -
Overexpression of C16orf74 is involved in aggressive pancreatic cancers
por: Nakamura, Toru, et al.
Publicado: (2016) -
Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients
por: TANAKA, KIMITAKA, et al.
Publicado: (2011) -
Potential risk of residual cancer cells in the surgical treatment of initially unresectable pancreatic carcinoma after chemoradiotherapy
por: Takano, Hironobu, et al.
Publicado: (2015)